MRVI
Maravai Lifesciences Holdings Inc
NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY
$3.68
+5.75% today
Updated 2026-04-30
Market cap
$542.79M
P/E ratio
—
P/S ratio
2.92x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$2 – $4
Volume
1.8M
Maravai Lifesciences Holdings Inc (MRVI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $539.68M | $577.80M | $1.27B | $1.92B | $2.28B | $1.49B | $1.01B |
| Cash & equivalents | $21.87M | $24.70M | $236.18M | $551.27M | $632.14M | $574.96M | $322.40M |
| Current assets | $53.80M | $60.55M | $331.60M | $740.04M | $847.90M | $699.91M | $429.15M |
| Total liabilities | $391.66M | $433.17M | $1.12B | $1.37B | $1.38B | $697.57M | $431.04M |
| Current liabilities | $35.92M | $29.56M | $130.78M | $93.78M | $110.14M | $87.47M | $56.97M |
| Long-term debt | $335.55M | $334.78M | $528.61M | $524.59M | $522.00M | $518.71M | $290.49M |
| Shareholder equity | $144.41M | $141.40M | $88.51M | $315.50M | $545.22M | $416.75M | $325.29M |
| Retained earnings | $-38.24M | $-42.38M | $854000.00 | $184.56M | $404.77M | $285.74M | $140.89M |
| Accounts receivable | $15.99M | $18.03M | $51.02M | $117.51M | $146.81M | $55.72M | $38.52M |
| Inventory | $14.31M | $14.20M | $33.30M | $51.56M | $43.15M | $51.40M | $50.08M |
| Goodwill | $224.28M | $224.28M | $224.28M | $152.77M | $283.67M | $326.03M | $159.88M |